Immix Biopharma, Inc. IMMX Lease Liability Payments - Remainder of Fiscal Year
Lease Liability Payments - Remainder of Fiscal Year at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s lease liability payments - remainder of fiscal year.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s lease liability payments - remainder of fiscal year?
- Immix Biopharma, Inc. (IMMX) reported lease liability payments - remainder of fiscal year of $158.33K in Q1 2026.
- How has Immix Biopharma, Inc.'s lease liability payments - remainder of fiscal year changed year-over-year?
- Immix Biopharma, Inc.'s lease liability payments - remainder of fiscal year increased by 3.5% year-over-year, from $152.97K to $158.33K.
- What does lease liability payments - remainder of fiscal year mean?
- The contractual cash obligations for operating and finance leases due within the remaining months of the current fiscal year. This provides a short-term view of the company's fixed lease commitments. It is a critical component for assessing near-term liquidity and cash flow requirements.